Related Experiment Videos
[Two sisters with dysferlinopathy manifesting different clinical phenotypes]
Yoichi Chiba1, Akiyo Shinde, Nobuo Kohara
1Department of Neurology, Kyoto University Graduate School of Medicine.
Rinsho Shinkeigaku = Clinical Neurology
|July 30, 2003
Summary
Dysferlinopathy in sisters presented differently: one with Miyoshi myopathy, the other with limb-girdle muscular dystrophy. This highlights the varied clinical presentations of this genetic muscle disorder.
Area of Science:
- Neurology
- Genetics
- Muscle Biology
Background:
- Dysferlinopathy is a group of inherited muscle disorders caused by mutations in the DYSF gene.
- It is characterized by progressive muscle weakness and degeneration, with varying clinical phenotypes.
- Understanding the genetic and molecular basis of phenotypic variability is crucial for diagnosis and treatment.
Observation:
- Two sisters with dysferlinopathy exhibited distinct clinical manifestations.
- Patient 1 presented with Miyoshi myopathy (MM), featuring calf muscle weakness and elevated creatine kinase (CK).
- Patient 2 displayed limb-girdle muscular dystrophy type 2B (LGMD2B) features, with proximal muscle weakness and elevated CK.
Findings:
- Muscle MRI revealed fatty degeneration in the calf muscles of patient 1, but not in patient 2.
- Immunohistochemistry confirmed dysferlin deficiency in the sarcolemma of both patients.
- Despite the same genetic defect, the affected siblings showed divergent disease progression and muscle involvement.
Implications:
- Sibling cases with differing dysferlinopathy phenotypes offer insights into the mechanisms of phenotypic variation.
- These findings underscore the complexity of genotype-phenotype correlations in genetic muscle disorders.
- Further research into factors influencing dysferlinopathy presentation is warranted for improved patient management.